Clinical Trial Update: The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether lowering aspirin dose modifies the innate immune response to endotoxin in patients with acute coronary syndrome has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2025-09-11